Gene Therapy webinar series – Episode 5: Genetic therapies and therapy developments for epileptic disorders

23 May 2024

Click here to register!

…TIMESLOT: Thursday 23 May 2024, 16:00 – 17:00 CEST

…THEME: Genetic therapies and therapy developments for epileptic disorders

…PRESENTERS: Prof. Dimitri Kullmann (UCL Queen Square Institute of Neurology, London, UK)

Dimitri Kullmann is a consultant neurologist at the National Hospital for Neurology and Neurosurgery, and professor of neurology at the UCL Queen Square Institute of Neurology. He trained in Oxford and London, and is a Fellow of the Academy of Medical Sciences and of the Royal Society. He specialises in neurocritical care and myasthenia gravis. His research interests centre on mechanisms underlying normal and abnormal circuit function in the brain, inherited and acquired disorders of ion channels (channelopathies) and gene therapy for epilepsy.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern